Quantumzyme specializes in biocatalysis and enzyme engineering to develop clean, green chemical processes. Its cutting-edge quantum mechanics, molecular modeling, and AI-driven enzyme design have led ...

Quantumzyme Corp. (OTC:QTZM), a pioneering biotechnology company specializing in computational enzyme engineering, has signed a Memorandum of Understanding (MOU) with Zummit Africa to establish a ...

Researchers demonstrate how pairing immunization with beneficial bacteria can eliminate intestinal infections.

Integrating biology into civil engineering, biogenic construction promotes sustainable practices that address environmental ...

The global drug discovery enzymes market is poised for significant expansion, projected to grow from USD 932.4 million in 2023 to USD 1,751.3 million by 2033, advancing at a compound annual growth ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Five Penn students were named 2025 Goldwater Scholars, which will grant them as much as $7,500 annually for up to two years ...

Tecan, a provider of advanced medtech engineering and technology development services, will exhibit at DeviceTalks Boston ...

Scientists at Oak Ridge National Laboratory have developed the first-ever method of detecting ribonucleic acid, or RNA, ...

The tiny device developed by Professors John Rogers, Igor Efimov, and Yonggang Huang can be inserted with a syringe, and then dissolve after it’s no longer needed.

Under Section 12 (g) of the Securities Exchange Act of 1934, a Form 10 becomes effective 60 days after filing. This transition to fully reporting status marks a key regulatory and strategic milestone ...

An INRS study based on natural selection is paving the way for very promising advances in biosurfactants. LAVAL, QC, April 3, ...